Altamira Therapeutics Ltd (CYTO) CHF0.01
Auris Medical Holding AG is a Switzerland-based biotechnologyompany focused on developing and commercializing therapeutics and medical devices for neurotology, rhinology and allergy and central nervous system (CNS) disorders.The Company is active in active in three areas such as: the development of oligonucleotides for extrahepatic therapeutic targets - OligoPhore platform; nasal sprays for protection against airborne viruses and allergens Bentrio or the treatment of vertigo AM-125 ; he development of therapeutics for intratympanic treatment of tinnitus Keyzilen or hearing loss Sonsuvi .
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.